Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Humana Inc (HUM) vs Annaly Capital Management, Inc. (NLY) Price & Performance

Humana IncTrade
Annaly Capital Management, Inc.Trade

Price performance (Past 24H)

Key statistics

Humana Inc vs Annaly Capital Management, Inc. — how do they compare? Humana Inc trades at $373.38 (market cap $46.31B), while Annaly Capital Management, Inc. trades at $23.11 (market cap $17.27B). The key difference: Humana Inc is far larger — about 2.7× Annaly Capital Management, Inc.'s market cap, and Annaly Capital Management, Inc. pays the higher dividend (13.09%). Which is the better fit depends on your goals.

HUMNLY
Market Cap
$46.31B$17.27B
Sector
HealthFinancials
52-Week High
$409.42$24.40
52-Week Low
$163.67$20.21
Enterprise Value
$53.67B
Dividend Yield
0.92%13.09%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Humana Inc

Humana (HUM) trades at $385.00, up 4.82% today, with a bullish technical outlook and analyst consensus price target of $399.53. Recent earnings beats in Q1 and Q2 2026, alongside revenue growth to $129.66 billion in 2025, support fundamentals, though net margins have compressed. The company is expanding its Medicaid business and targeting margin improvements by 2027.

The stock offers upside to consensus targets but faces risks from Medicare Advantage margin pressures and regulatory changes. Profitability trends are weak despite revenue growth, requiring successful cost management to meet 2028 targets. Institutional sentiment is mixed with a majority hold rating.

Annaly Capital Management, Inc.

Annaly Capital Management (NLY) trades at $23.04, up 1.68% today, with a bullish technical outlook and strong earnings momentum after beating Q2 2026 EPS estimates. The stock shows robust fundamentals with a P/E of 5.57, ROE of 20.66%, and a net income margin of 92.77%. Recent news highlights inclusion in Zacks' Strong Buy lists and a focus on high-yield income, supported by a $0.75 dividend payment scheduled for July 2026.

Outlook is positive with analyst consensus favoring Buy ratings (57.15%) and a $24.50 price target, implying ~6% upside. Key risks include interest rate sensitivity and mortgage market volatility, but diversified housing finance strategies and consistent dividend coverage provide stability. Investment appeal centers on value valuation and income generation.

Returns comparison

Trailing returns across standard periods

About Humana Inc

Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.

Read more on HUM

About Annaly Capital Management, Inc.

Annaly Capital Management Inc is an American mortgage real estate investment trust. The company segments its operations into Residential and Commercial real estate investments. While Annaly's Residential assets are primarily comprised of agency mortgage-backed securities and debentures, it is primarily invested in commercial mortgage loans and mortgage-backed securities in its Commercial unit through its subsidiary, Annaly Commercial Real Estate Group. Agency mortgage-backed securities and debentures make up the majority of the company's overall portfolio. Most of the company's counterparties are located in the U.S. Annaly generates nearly all of its revenue from the spread between interest earned on its assets and interest payments made on its borrowings.

Read more on NLY